Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesUpdates on the Pathophysiology and Management of Acne Rosacea
Postgraduate Medicine, 09/30/09
Elsaie ML et al. – Recent molecular studies suggest that an altered innate immune response is involved in the pathogenesis of the vascular and inflammatory disease seen in patients with rosacea. These findings may help explain the benefits of current treatments and suggest new therapeutic strategies helpful for alleviating this disease. The goals of therapy include reduction of papules, pustules, erythema, physical discomfort, and an improvement in quality of life. Standard topical treatment agents include metronidazole, azelaic acid, and sodium sulfacetamide–sulfur. Second–line therapies include benzoyl peroxide, clindamycin, calcineurin inhibitors, and permethrin. There are also various systemic therapy options.
Today in Cosmetic Derm/Acne...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing the best treatments for acne
The Clinical Advisor, 11/03/09
Management of acne vulgaris: an evidence-based update
Clinical and Experimental Dermatology, 11/02/09
Alefacept for Severe Alopecia Areata
Archives of Dermatology, 11/17/09
Sponsor
Article Search
Sponsor